Valbiotis SA (FR:ALVAL) has released an update.
Valbiotis, a French laboratory specializing in dietary supplements aimed at preventing metabolic disorders, has disclosed its share capital structure for May 2024, with 15,794,596 shares and 16,510,598 exercisable voting rights. The company reminds shareholders of the obligation to declare share ownership thresholds exceeding 5%, under penalty of losing voting rights. Valbiotis continues to innovate in health supplements, with a strong academic partnership presence and support from the European Union.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.